Quality of life after intra-arterial treatment for acute ischemic stroke in the MR CLEAN trialUpdate

Jennifer Schreuders*, Lucie A. van den Berg, Puck S. S. Fransen, Olvert A. Berkhemer, Debbie Beumer, Hester F. Lingsma, Robert J. van Oostenbrugge, Wim H. van Zwam, Charles B. L. M. Majoie, Aad van der Lugt, Paul L. M. de Kort, Yvo B. W. E. M. Roos, Diederik W. J. Dippel, MR CLEAN Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)

Abstract

Background Health-related quality of life measured with the EuroQol Group 5-Dimension Self-Report Questionnaire was one of the secondary outcomes in the Multicenter Randomized Clinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN). We reported no statistically significant difference in EuroQol Group 5-Dimension Self-Report Questionnaire score between the intervention and control groups, but deaths were not included.

Aims Reanalyze the effect of intra-arterial treatment for large vessel occlusion in acute ischemic stroke patients on health-related quality of life in more detail. We now include patients who died during follow-up.

Methods The EuroQol Group 5-Dimension Self-Report Questionnaire questionnaires were obtained 90 days after treatment. We used the Dutch tariff to derive a utility index from the EuroQol Group 5-Dimension Self-Report Questionnaire score. Treatment effect was estimated with the Mann-Whitney U test and linear regression. The effect of treatment on the distribution of EuroQol Group 5-Dimension Self-Report Questionnaire dimension scores was assessed with ordinal logistic regression.

Results We obtained EuroQol Group 5-Dimension Self-Report Questionnaire scores from 457 (91.7%) of the 500 patients, including 108 who died before follow-up. Median EuroQol Group 5-Dimension Self-Report Questionnaire score in the intervention group was 0.57, and 0.39 in the control group (p=0.03). Treatment effect estimated with linear regression was 0.07 (95%CI: -0.001 to 0.143). Treatment specifically affected EuroQol Group 5-Dimension Self-Report Questionnaire dimensions mobility (OR: 0.43, 95%CI: 0.29-0.66), self-care (OR: 0.60, 95%CI: 0.41-0.89), and usual activities (OR: 0.53, 95%CI: 0.36-0.79).

Conclusion Treatment had a limited effect on quality of life, as measured with the EuroQol Group 5-Dimension Self-Report Questionnaire. Nevertheless, patients with acute ischemic stroke caused by an intracranial occlusion in the anterior circulation, who had intra-arterial treatment, experience better health-related quality of life than patients without intra-arterial treatment.

Original languageEnglish
Pages (from-to)708-712
Number of pages5
JournalInternational journal of stroke
Volume12
Issue number7
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Ischemic stroke
  • intra-arterial treatment
  • quality of life
  • EuroQol Group 5-Dimension Self-Report Questionnaire
  • THROMBECTOMY

Cite this